Malnutrition in liver cirrhosis:the influence of protein and sodium

Sareh Eghtesad, Hossein Poustchi, Reza Malekzadeh, Sareh Eghtesad, Hossein Poustchi, Reza Malekzadeh

Abstract

Protein calorie malnutrition (PCM) is associated with an increased risk of morbidity and mortality in patients with cirrhosis and occurs in 50%-90% of these patients. Although the pathogenesis of PCM is multifactorial, alterations in protein metabolism play an important role. This article is based on a selective literature review of protein and sodium recommendations. Daily protein and sodium requirements of patients with cirrhosis have been the subject of many research studies since inadequate amounts of both can contribute to the development of malnutrition. Previous recommendations that limited protein intake should no longer be practiced as protein requirements of patients with cirrhosis are higher than those of healthy individuals. Higher intakes of branched-chain amino acids as well as vegetable proteins have shown benefits in patients with cirrhosis, but more research is needed on both topics. Sodium restrictions are necessary to prevent ascites development, but very strict limitations, which may lead to PCM should be avoided.

Keywords: Ascites; Liver Cirrhosis; Malnutrition.

References

    1. Johnson TM, Overgard EB, Cohen AE, DiBaise JK. Nutrition Assessment and Management in Advanced Liver Disease. Nutr Clin Pract. 2013;28:15–29.
    1. Cheung K, Lee SS, Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol. 2012;10:117–25.
    1. McCullough AJ, Tavill AS. Disordered energy and protein metabolism in liver disease. Semin Liver Dis. 1991;11:265–77.
    1. Charlton MR. Protein metabolism and liver disease. Baillieres Clin Endocrinol Metab. 1996;10:617–35.
    1. Gheorghe L, Iacob R, Vadan R, Iacob S, Gheorghe C. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet. Rom J Gastroenterol. 2005;14:231–8.
    1. Kawaguchi T, Izumi N, Charlton MR, Sata M. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology. 2011;54:1063–70.
    1. Achord JL. Malnutrition and the role of nutritional support in alcoholic liver disease. Am J Gastroenterol. 1987;82:1–7.
    1. Kalaitzakis E, Simren M, Olsson R, Henfridsson P, Hugosson I, Bengtsson M. et al. Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life. Scand J Gastroenterol. 2006;41:1464–72.
    1. Kugelmas M. Preliminary Observation: Oral Zinc Sulfate Replacement is Effective in Treating Muscle Cramps in Cirrhotic Patients. J Am Coll Nutr. 2000;19:13–5.
    1. Amodio P, Caregaro L, Patteno E, Marcon M, Del Piccolo F, Gatta A. Vegetarian diets in hepatic encephalopathy: facts or fantasies? Dig Liver Dis 2001;33:492-500. facts or fantasies? Dig Liver Dis. 2001;33:facts or fantasies? Dig Liver Dis 2001;33.
    1. Figueiredo FA, De Mello Perez R, Kondo M. Effect of liver cirrhosis on body composition: evidence of significant depletion even in mild disease. J Gastroenterol Hepatol. 2005;20:209–16.
    1. Petrides AS, De Fronzo RA. Failure of glucagon to stimulate hepatic glycogenolysis in well-nourished patients with mild cirrhosis. Metabolism. 1994;43:85–9.
    1. Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Muller MJ. et al. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr. 1997;16:43–55.
    1. Kalaitzakis E, Bosaeus I, Ohman L, Björnsson E. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am J Clin Nutr. 2007;85:808–15.
    1. Greco AV, Mingrone G, Benedetti G, Capristo E, Tataranni PA, Gasbarrini G. Daily energy and substrate metabolism in patients with cirrhosis. Hepatology. 1998;27:346–50.
    1. Müller MJ, Böttcher J, Selberg O, Weselmann S, Böker KH, Schwarze M. et al. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr. 1999;69:1194–201.
    1. McCullough AJ, Raguso C. Effect of cirrhosis on energy expenditure. Am J Clin Nutr. 1999;69:1066–8.
    1. Fuhrman MP, Charney P, Mueller CM. Hepatic Proteins and Nutrition Assessment. J Am Diet Assoc. 2004;104:1258–64.
    1. Casati A, Muttini S, Leggieri C, Colombo S, Giorgi E, Torri G. Rapid turnover proteins in critically ill ICU patients. Negative acute phase proteins as nutritional indicators? Minerva Anestesiol. 1998;64:345–50.
    1. Fernandes SA, Bassani L, Nunes FF, Aydos ME, Alves AV, Marroni CA. Nutritional assessment in patients with cirrhosis. Arq Gastroenterol. 2012;49:19–27.
    1. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN. What is Subjective Global Assessment of Nutricional Status? JPEN Journal of Parenteral and Enteral Nutrition. 1987;11:8–13.
    1. Alvares-da-Silva MR, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition. 2005;21:113–7.
    1. Álvares-da-Silva MR, Silveira TR. Non-dominant handgrip strength study in healthy individualsDetermination of reference values to be used in dynamometry. GED. 1998;17:203–6.
    1. Cordoba J, Lopez-Hellin J, Planas M, Sabin P, Sanpedro F, Castro F. et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol. 2004;41:38–43.
    1. Swart GR, van den Berg JW, van Vuure JK, Rietveld T, Wattimena DL, Frenkel M. Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake. Clin Nutr. 1989;8:329–36.
    1. Swart GR, Zillikens MC, van Vuure JK, van den Berg JW. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. BMJ. 1989;299:1202–3.
    1. Hidaka H, Nakazawa T, Kutsukake S, Yamazaki Y, Aoki I, Nakano S. et al. The efficacy of nocturnal administration of branched-chain amino acid granules to improve quality of life in patients with cirrhosis. J Gastroenterol. 2013;48:269–76.
    1. Sako K, Imamura Y, Nishimata H, Tahara K, Kubozono O, Tsubouchi H. Branched-chain amino acids supplements in the late evening decrease the frequency of muscle cramps with advanced hepatic cirrhosis. Hepatol Res. 2003;26:327–9.
    1. Zillikens MC, van den Berg JW, Wattimena JL, Rietveld T, Swart GR. Nocturnal oral glucose supplementationThe effects on protein metabolism in cirrhotic patients and in healthy controls. J Hepatol. 1993;17:377–83.
    1. Uribe M, Marquez MA, Garcia Ramos G, Ramos-Uribe MH, Vargas F, Villalobos A. et al. Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein dietsA controlled crossover study. Dig Dis Sci. 1982;27:1109–16.
    1. Shaw S, Worner TM, Lieber CS. Comparison of animal and vegetable protein sources in the dietary management of hepatic encephalopathy. The American journal of clinical nutrition. 1983;38:59–63.
    1. Greenberger NJ, Carley J, Schenker S, Bettinger I, Stamnes C, Beyer P. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Am J Dig Dis. 1977;22:845–55.
    1. Weber FL Jr. Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects. Gastroenterology. 1985;89:538–44.
    1. de Bruijn KM, Blendis LM, Zilm DH, Carlen PL, Anderson GH. Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy. Gut. 1983;24:53–60.
    1. Cardenas A, Arroyo V. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites. Best Pract Res Clin Endocrinol Metab. 2003;17:607–22.
    1. Gines P, Cardenas A. The management of ascites and hyponatremia in cirrhosis. Semin Liver Dis. 2008;28:43–58.
    1. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087–107.
    1. Desai HG. Salt Restriction in Ascites with Cirrhosis of Liver: Will Enhanced Salt Restriction Increase Longevity? J Assoc Physicians India. 2006;54:504.
    1. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F. et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38:258–66.
    1. Reynolds TB, Lieberman FL, Goodman AR. Advantages of treatment of ascites without sodium restriction and without complete removal of excess fluid. Gut. 1978;19:549–53.
    1. Gauthier A, Levy VG, Quinton A, Michel H, Rueff B, Descos L. et al. Salt or no salt in the treatment of cirrhotic ascites: A randomised study. Gut. 1986;27:705–9.
    1. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55Suppl6:vi1–12.
    1. American Heart Association 2010 Dietary Guidelines. 2009.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe